ArticleAnnals of surgical oncology2026

Association of Adjuvant Immunotherapy with Improved Survival for Stage II-III Esophageal Cancer: 4-Year National Perspective.

Sara Sakowitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.